Country: New Zealand
Bahasa: Inggeris
Sumber: Medsafe (Medicines Safety Authority)
Lumiracoxib 200mg (release testing to occur at Novartis AG, Lichstrasse, Basel.)
Novartis New Zealand Ltd
Lumiracoxib 200 mg (release testing to occur at Novartis AG, Lichstrasse, Basel.)
200 mg
Film coated tablet
Active: Lumiracoxib 200mg (release testing to occur at Novartis AG, Lichstrasse, Basel.) Excipient: Croscarmellose sodium Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry black 00F17713 Opadry red 00F15613 Opadry white 00F18296 Povidone Titanium dioxide
Blister pack, PVC/Al x 2 tablets, 2 tablets
Prescription
Prescription
Novartis Grimsby Limited
Package - Contents - Shelf Life: Blister pack, PVC/Al x 2 tablets - 2 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 10 tablets - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 20 tablets - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 30 tablets - 30 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 50 tablets - 50 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 100 tablets - 100 tablets - 36 months from date of manufacture stored at or below 30°C
2003-01-09